Hypera buys Boehringer brands

Hypera buys Boehringer brands

M&A Equity Brazil Europe

Brazil's Hypera Pharma said on Wednesday that it has agreed to buy two over-the-counter medicine brands from Germany's Boehringer Ingelheim for BRL1.3 billion ($320 million). In the deal, Hypera will acquire Buscopan, a leading OTC medication for sto

Already have an account?

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial